Loss of FBPase facilitates the Warburg effect in cancer
Glucose uptake and lactate secretion are two common indicators of glycolysis. Upon FBPase silencing, glucose uptake and lactate secretion were significantly increased in various cancer cells (BLBC [
20,
22], ccRCC [
24], gastric cancer [
26], HCC [
14,
15,
80‐
82], lung cancer [
12,
13], and pancreatic cancer cell lines [
28]). TXNIP, a commonly used intracellular glucose sensor [
92], and insulin, the major hormone regulating glucose uptake [
53], were tested in cancer cell lines. FBP1 expression decreased glucose uptake, TXNIP induction and insulin sensitivities, whereas the loss of FBP1 enhanced glucose uptake, TXNIP induction and insulin sensitivities [
13,
16,
23,
24]. These finding indicated that FBP1 was critical in inhibiting glucose uptake, as exemplified by the downregulation of glucose and insulin sensitivities. Accumulation of lactate is another common feature of cancer cells and is involved in the progression of malignancies [
93]. Lactate secretion was significantly decreased in FBP1-expressing cells [
12,
13,
15,
22,
26,
80]. The extracellular acidification rate (ECAR) is the glycolysis rate after glucose treatments and is equal to the glycolysis capacity after oligomycin treatment. In HCC, studies have shown that FBP1 significantly reduced the ECAR, while FBP1 suppression did the opposite [
14].
Besides, certain regulators in carcinogenesis were found to reprogram cancer cell metabolism by suppressing FBP1. NMP1, a multifaceted nucleolar protein, was found to stimulate glucose uptake and lactate generation in pancreatic cancer cells by directly inhibiting FBP1 expression. Restoring FBP1 in pancreatic cancer cells reversed the NPM1-induced dysfunction of glucose metabolism [
28]. TRIM proteins, members of a subfamily of the RING type E3 ubiquitin ligases [
94], were found to increase glucose consumption and lactate production in HCC cells by promoting FBP1 degradation. Importantly, the effect of TRIM28 was largely inhibited by the co-expression of FBP1 [
80]. c-Myc, a crucial downstream factor of Wnt/β-catenin signalling, was found to be negatively correlated with the level of FBP1 in breast cancer cells [
20]. As c-Myc is also a transcription factor involved in metabolic reprogramming [
95], it is reasoned that the inhibitory effect of FBP1 in glycolysis might be mediated partially by the downregulation of c-Myc. However, the precise mechanism by which FBP1 regulates Wnt/β-catenin signalling warrants further investigation [
20].
In addition, the consuming oxygen during OXPHOS and aerobic glycolysis is totally different. The reliance of tumour cells on glycolysis for energy production causes them to decrease oxygen consumption to adapt to the hypoxia tumour microenvironment. The basal oxygen consumption rate (OCR) was found to be significantly decreased in FBP1-knockdown cells, whereas it was significantly increased in FBP1-expressing cells. Similar results were obtained in the analyses of ATP-linked and maximal OCR [
12,
13,
22], indicating that FBP1 is involved in the switch from glycolysis to OXPHOS.
FBPase silencing helped maintain energy homeostasis in cancer cells. For every glucose molecule a cell consumes, aerobic glycolysis produces 2 ATP, whereas OXPHOS produces 36 ATP. Under normoxic conditions, expression or knockdown of FBP1 did not alter the steady-state level of ATP in BLBC or luminal cells. However, under hypoxia, knockdown of FBP1 helped maintain ATP production, whereas expression of FBP1 significantly decreased ATP production in BCLC and HCC [
15,
22]. In gastric cancer cells, studies have found that FBP2 overexpression significantly reduces the levels of ATP and lactate through interference of the Akt-mTOR pathway [
25].
Stable isotope-resolved metabolomic (SIRM) analysis was used to investigate the metabolic fate of [U-
13C]-glucose, which directly produces glycolytic intermediates that contain six or three
13C atoms (M6/M3 species) and the intermediates of the first turn of the tricarboxylic acid (TCA) cycle that contain two
13C atoms (M2 species). When FBP1 was overexpressed, M3 enrichment of lactate was significantly inhibited, and the levels of the glycolytic intermediates F-1,6-BP (M6 species), dihydroxyacetone phosphate (M3 species), and glucose-6-phosphate were decreased. Ectopic FBP1 tended to inhibit M2 enrichment of TCA cycle intermediates, such as succinate, fumarate and malate, as well as M4 enrichment of citrate [
15,
22,
96]. Furthermore, FBP1 expression reduced M5 enrichment of the ribosyl unit of ribonucleotides and their derivatives (i.e., NAD+, and UDPG), suggesting that FBP1 suppressed de novo nucleic acid synthesis through the pentose phosphate pathway [
15,
22,
24]. In line with these findings, the ratio of NADP+/NADPH was increased in FBP1-expressing cells, whereas this ratio was decreased in FBP1-knockdown cells. The production of the M3 isotopologues of glycerol-3-phosphate (G3P) and serine was significantly reduced in FBP1-expressing cells [
22]. Reduced glucose-dependent TCA flux is known to increase anaplerotic glutamine flux [
97]; elevated glutamine uptake and enrichment of glutamine-derived TCA cycle intermediates (M4 species) were observed upon forced FBPase expression [
21,
24]. Increased oxidation of branched chain amino acids (BCAAs) (valine, leucine, and isoleucine), except for glutamine, was also found in brain metastatic cancer cells, with upregulation of FBP2, but not FBP1, and enhanced gluconeogenesis in the absence of glucose [
21].
All these data imply that loss of FBPase facilitates glycolytic flux and decreases OXPHOS in cancer cells.
How cancer cells switch OXPHOS to aerobic glycolysis by FBPase silencing
Key enzymes of glucose uptake and aerobic glycolysis in cancer cells were found to decrease significantly when FBPase was expressed. In HCC, FBP1 expression was found to significantly decrease the levels of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA) [
82]. Three enzymes are involved in catalysing the irreversible steps of glycolysis: hexokinase (HK) [
98,
99], phosphofructokinase (PFK) [
100], and pyruvate kinase (PK) [
101]. While dimeric PKM2 diverts glucose metabolism towards anabolism through glycolysis, tetrameric PKM2 promotes the flux of glucose-derived carbons for ATP production via oxidative phosphorylation [
101]. FBP1 expression significantly decreased the tetrameric PKM2, whereas knockdown of FBP1 increased the formation of tetrameric PKM2. In addition, FBP1 expression was found to significantly decrease the HK2 and PFK1 levels in HCC [
15]. All these results indicated that the loss of FBP1 activated GLUT1, PKM2, HK2, PFK1 and LDHA, which facilitated glucose uptake and lactate production and triggered the switch to aerobic glycolysis.
In addition, FBP1 expression was found to be correlated with higher complex I activity. TFB1M is a nuclear gene, encoding mitochondrial transcription factor, which is essential for mitochondrial biogenesis and OXPHOS [
102]. When FBP1 was expressed, TFB1M and its targets from mitochondrial complex I, ND1 and ND5, were found to be increased, indicating that the increase in complex I activity is the main factor underlying the increase in OXPHOS [
22].